Celanese

Textile Yarn Market worth $18.5 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, June 13, 2023
Workforce, Flower, Asahi Kasei, Celanese, Vegetable, Zinc, Chelation, Ectomycorrhiza, Carbon, USD, Film, Agriculture, Microbial inoculant, Sport, Growth, Biopesticide, Powder, Cereal, Liquid, Boron, Soil, Polymer, Iron, Clothing, Dyeing, Textile, Fertilizer, Mycorrhiza, Molybdenum, Copper, Fertigation, Form, Region

CHICAGO, June 13, 2023 /PRNewswire/ -- The Textile Yarn Market is estimated at USD 14.4 billion in 2023 and is projected to reach USD 18.5 billion by 2028, at a CAGR of 5.1% from 2023 to 2028 according to a report published by MarketsandMarkets™.

Key Points: 
  • CHICAGO, June 13, 2023 /PRNewswire/ -- The Textile Yarn Market is estimated at USD 14.4 billion in 2023 and is projected to reach USD 18.5 billion by 2028, at a CAGR of 5.1% from 2023 to 2028 according to a report published by MarketsandMarkets™.
  • Key factor contributing to the growing demand for textile yarn is the expanding middle class in emerging economies.
  • The plant segment in the textile yarn market is experiencing growth due to several key factors.
  • The polyester segment in the artificial yarn category of the textile yarn market is experiencing significant growth due to widespread adoption of polyester yarn in various industries and applications.

Textile Yarn Market worth $18.5 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, June 13, 2023
Workforce, Flower, Asahi Kasei, Celanese, Vegetable, Zinc, Chelation, Ectomycorrhiza, Carbon, USD, Film, Agriculture, Microbial inoculant, Sport, Growth, Biopesticide, Powder, Cereal, Liquid, Boron, Soil, Polymer, Iron, Clothing, Dyeing, Textile, Fertilizer, Mycorrhiza, Molybdenum, Copper, Fertigation, Form, Region

CHICAGO, June 13, 2023 /PRNewswire/ -- The Textile Yarn Market is estimated at USD 14.4 billion in 2023 and is projected to reach USD 18.5 billion by 2028, at a CAGR of 5.1% from 2023 to 2028 according to a report published by MarketsandMarkets™.

Key Points: 
  • CHICAGO, June 13, 2023 /PRNewswire/ -- The Textile Yarn Market is estimated at USD 14.4 billion in 2023 and is projected to reach USD 18.5 billion by 2028, at a CAGR of 5.1% from 2023 to 2028 according to a report published by MarketsandMarkets™.
  • Key factor contributing to the growing demand for textile yarn is the expanding middle class in emerging economies.
  • The plant segment in the textile yarn market is experiencing growth due to several key factors.
  • The polyester segment in the artificial yarn category of the textile yarn market is experiencing significant growth due to widespread adoption of polyester yarn in various industries and applications.

Two Vermonters voted as top captive insurance professionals in the world

Retrieved on: 
Thursday, May 11, 2023
Vermont Department of Motor Vehicles, General counsel, Farmer, International Center, United Shipping & Trading Company, Professional, DFR, AIG, Associate, Government, Gold, Division, Knowledge, Growth, Financial regulation, Region, Captive insurance, Farmers Business Network, Environment, National Risk Register, Legislation, Insurance, Management, Celanese

MONTPELIER, Vt., May 11, 2023 /PRNewswire-PRWeb/ -- The Captive Insurance Division of the Vermont Department of Financial Regulation (DFR) Deputy Commissioner of Captive Insurance Sandy Bigglestone, and Regional Managing Director – Americas for Aon Captive & Insurance Management Nancy Gray, were voted to top spots by their peers in Captive Review's Power 50 Awards earlier this year. According to the Captive Review, over 7,800 captive insurance professionals around the world submitted their nominations and nominees were then judged on how they best met the criteria of influence, innovation, visibility/accessibility, skill/ability, and how dedicated they are to helping the broader industry.

Key Points: 
  • They placed #3 and #1 in Captive Review's Power 50 Awards, which recognizes the world's top captive insurance professionals.
  • MONTPELIER, Vt., May 11, 2023 /PRNewswire-PRWeb/ -- The Captive Insurance Division of the Vermont Department of Financial Regulation (DFR) Deputy Commissioner of Captive Insurance Sandy Bigglestone, and Regional Managing Director – Americas for Aon Captive & Insurance Management Nancy Gray, were voted to top spots by their peers in Captive Review's Power 50 Awards earlier this year.
  • In 2022, Bigglestone was promoted to Deputy Commissioner of the Captive Division, leading Vermont's 30 captive insurance regulators.
  • Previously, she served as a director and treasurer of the International Center for Captive Insurance Education and as a director and treasurer of the Vermont Captive Insurance Association.

Celanese Announces Vamac® AEM Price Increases

Retrieved on: 
Thursday, May 11, 2023
Chemicals, Plastics, Manufacturing, CE, AEM, Corporation, NYSE, Celanese, Rare-earth element

Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, announced price increases for Vamac® AEM by 2 EUR/kg in the EMEA region and by 2.2 USD/kg in Asia Pacific and the Americas.

Key Points: 
  • Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, announced price increases for Vamac® AEM by 2 EUR/kg in the EMEA region and by 2.2 USD/kg in Asia Pacific and the Americas.
  • These price increases will be effective on June 1, 2023, or as contracts otherwise allow.
  • Additionally, individual grades may be subject to higher increases than specified above.

Celanese Corporation Reports First Quarter 2023 Earnings

Retrieved on: 
Tuesday, May 9, 2023
Chemicals, Plastics, Manufacturing, Mitsui, Amine, Eye, GAAP, Research, Ratio, EBIT, JV, Science and technology in Asia, EBITDA, Johns Hopkins University, Acetic acid, Acetyl group, Growth, Acetic anhydride, M&M, Environment, VAM, Bank, Oil, Celanese

The Acetyl Chain delivered first quarter net sales of $1.3 billion, a 10 percent increase from the prior quarter due to a 10 percent increase in volume.

Key Points: 
  • The Acetyl Chain delivered first quarter net sales of $1.3 billion, a 10 percent increase from the prior quarter due to a 10 percent increase in volume.
  • While demand for acetyls in Europe and Asia improved significantly over the prior quarter, volume in the first quarter lagged the same quarter of last year by 9 percent and was insufficient to support pricing expansion.
  • Engineered Materials reported first quarter net sales of $1.6 billion, a 32 percent increase from the prior quarter.
  • The M&M contribution to EM earnings increased sequentially through volume recovery and approximately $10 million in synergies delivered across the quarter.

Pharmaceutical & Medical Polymers Market Report 2023: Rising Need for Economical, Biodegradable and Eco-Friendly Polymers to Fuel Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 2, 2023
Chemicals, Plastics, Pharmaceutical, Health, Manufacturing, Thermoset polymer matrix, Taste, Tissue, Pressure, Maintenance, Partnership, TPE, Elastomer, Gel, Henkel, Electronics, Administration, Agriculture, Dental implant, Infection, Borealis, Lung compliance, Polymer, Table tennis rubber, Oxazoline, LyondellBasell, Drug, Sumitomo Chemical, Temperature, Research, Catheter, Element, Siloxane, Instrument, Gelatin, Type, Organization, Excipient, Pound (currency), Nature, Polyglycolide, Tissue engineering, Stent, Self-healing, 3D bioprinting, Polyethylene, PH, Environment, Kuraray, Adhesive, Medical device, 3D printing, Pharmaceutical industry, Fine chemical, Speciality chemicals, Chemical, Celanese

Driven by the significant advancements in this domain and rising demand for novel medical therapies and devices, we believe that the pharmaceutical polymers / medical polymers market is likely to witness a steady growth over the coming years.

Key Points: 
  • Driven by the significant advancements in this domain and rising demand for novel medical therapies and devices, we believe that the pharmaceutical polymers / medical polymers market is likely to witness a steady growth over the coming years.
  • Driven by the rising need for economical, biodegradable and eco-friendly medical-grade polymers, the pharmaceutical polymers / medical polymers market is anticipated to witness steady growth in the foreseen future.
  • Question 6: Which segment is likely to have the largest share in the pharmaceutical polymers / medical polymers?
  • Answer: Currently, the medical devices segment dominates the pharmaceutical polymers / medical polymers market.

Celanese Corporation Declares Quarterly Dividend of $0.70 Per Share

Retrieved on: 
Wednesday, April 19, 2023
Chemicals, Plastics, Manufacturing, CE, NYSE, Corporation, Celanese, Holding company

Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, today declared a quarterly cash dividend of $0.70 per share on its common stock, payable May 15, 2023.

Key Points: 

Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, today declared a quarterly cash dividend of $0.70 per share on its common stock, payable May 15, 2023.
The dividend is payable to stockholders of record as of May 1, 2023.

Celanese to Hold First Quarter Earnings Conference Call on May 10, 2023

Retrieved on: 
Wednesday, April 5, 2023
Chemicals, Plastics, Other Manufacturing, Manufacturing, Outlook, Webcast, Calendar, CE, Corporation, NYSE, Celanese, Nightclub

Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced that it will host a conference call to discuss its first quarter 2023 results on Wednesday, May 10, 2023, beginning at 10:00 a.m. Eastern time.

Key Points: 
  • Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced that it will host a conference call to discuss its first quarter 2023 results on Wednesday, May 10, 2023, beginning at 10:00 a.m. Eastern time.
  • The company will distribute its first quarter earnings press release via newswire after the New York Stock Exchange closes on Tuesday, May 9, 2023.
  • The earnings press release and prepared remarks will also be available at https://investors.celanese.com after market close on Tuesday, May 9, 2023.
  • A replay of the conference call will be available on demand on May 10, 2023, from 12:00 p.m. Eastern time until May 24, 2023, 12:00 a.m. Eastern time, at the following number:

Celanese Announces Agreement with Glaukos Corporation for Sustained Release Glaucoma Treatment

Retrieved on: 
Wednesday, April 5, 2023
Chemicals, Plastics, Medical Devices, Health, Manufacturing, Pharmaceutical, Optical, Glaucoma, CE, Idose, Therapy, Celanese, New Drug Application, Intraocular pressure, Ocular hypertension, Corporation, Patient, Ophthalmology, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, NYSE, Food, Medical device

Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, today announced that it has entered into an agreement with Glaukos Corporation to supply its VitalDose® Drug Delivery Platform for use as a component in Glaukos’ iDose® TR, a micro-invasive intraocular implant designed to lower intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension.

Key Points: 
  • Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, today announced that it has entered into an agreement with Glaukos Corporation to supply its VitalDose® Drug Delivery Platform for use as a component in Glaukos’ iDose® TR, a micro-invasive intraocular implant designed to lower intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension.
  • iDose TR is designed to address patient non-adherence and chronic side effects associated with topical medications by providing 24/7, long-duration therapy.
  • Glaukos submitted a New Drug Application to the U.S. Food and Drug Administration for iDose TR in February 2023, which has not yet been approved.
  • Sustained delivery of therapeutics has become an increasingly important approach to treating glaucoma.

5E Advanced Materials Appoints Experienced Global Executive as CEO

Retrieved on: 
Tuesday, March 21, 2023
Hoechst, IPO, Ambassador, University, Advanced Materials, Senior, Long Beach, California, California State University, Long Beach, Nissan USA, Engineering, Stanford University, Empowerment, Boron, Dean, Senior plc, ASX, Ford Motor Company, Lithium, Manufacturing, Government, Sale, Critical infrastructure, NYSE, Primary energy, Business administration, Dean Smith (engineer), Doe, Celanese, Nikola Corporation, Transport, Master of Business Administration, University of Nebraska–Lincoln, Education, Complex, Management, Science

HOUSTON, March 21, 2023 (GLOBE NEWSWIRE) -- 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”), a boron and lithium company with U.S. government Critical Infrastructure designation for its 5E Boron Americas (Fort Cady) Complex, is pleased to advise that it has appointed Ms. Susan Seilheimer Brennan as the Company’s new Chief Executive Officer commencing April 24, 2023.

Key Points: 
  • Prior to her appointment at 5E Advanced Materials, Ms. Brennan was President and CEO of NYSE-listed Romeo Power (NYSE:RMO), a leader in advanced electrification solutions for commercial vehicles
    HOUSTON, March 21, 2023 (GLOBE NEWSWIRE) -- 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”), a boron and lithium company with U.S. government Critical Infrastructure designation for its 5E Boron Americas (Fort Cady) Complex, is pleased to advise that it has appointed Ms. Susan Seilheimer Brennan as the Company’s new Chief Executive Officer commencing April 24, 2023.
  • Ms. Brennan has an extensive global leadership background, particularly in the battery technology and electric vehicle industries.
  • Most recently, as the CEO of NYSE listed Romeo Power (NYSE: RMO), she was responsible for leading an organization which developed a suite of battery technology products designed for commercial vehicles.
  • As CEO, Ms. Brennan will lead all facets of the Company as it progresses its business strategy to become a fully integrated globally significant producer of boron, lithium and advanced materials based in the United States of America.